Functional MR-guided Stereotactic Body Radiation Therapy of Prostate Cancer

NATerminatedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 10, 2018

Primary Completion Date

November 25, 2021

Study Completion Date

November 25, 2021

Conditions
Prostatic Neoplasms
Interventions
RADIATION

Stereotactic body RT with MR-guided boost

Patients will receive radiotherapy over 5 fractions delivered once per week over 29 days, with 7.25 Gy per fraction to the whole prostate and 8 Gy per fraction to the dominant intraprostatic lesion. There will be a minimum of 120 hours and maximum of 192 hours between fractions. The entire course of treatment should be completed within no less than 27 days and no longer than 30 days.

Trial Locations (1)

R3E 0V9

CancerCare Manitoba, Winnipeg

Sponsors
All Listed Sponsors
lead

CancerCare Manitoba

OTHER